Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-30 Sale | 2025-06-03 4:10 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 50,937 | $305 | $15,535,784 | 72,024 (Indirect Direct) | View |
| 2025-05-15 Sale | 2025-05-19 4:17 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director | 11,250 | $277.71 | $3,124,217 | 20,804 (Indirect Direct) | View |
| 2024-08-29 Purchase | 2025-05-12 4:05 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Reitan Colleen F Director | 36 | $287.85 | $10,363 | 2,333 (Direct) | View |
| 2025-04-16 Sale | 2025-05-12 4:05 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Reitan Colleen F Director | 36 | $232.86 | $8,383 | 2,333 (Direct) | View |
| 2025-03-21 Sale | 2025-03-25 4:10 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 9,766 | $293.36 | $2,864,985 | 20,902 (Indirect Direct) | View |
| 2025-03-24 Sale | 2025-03-25 4:09 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 7,440 | $299 | $2,224,560 | 28,036 (Indirect Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:22 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 2,755 | $242.94 | $669,304 | 21,857 (Indirect Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:22 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 471 | $243.78 | $114,820 | 35,830 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 2,557 | $242.92 | $621,150 | 33,042 (Indirect Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,264 | $243.78 | $308,141 | 57,608 (Indirect Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:20 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 3,877 | $243.79 | $945,165 | 135,335 (Indirect Direct) | View |
| 2025-02-28 Sale | 2025-03-03 4:32 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 2,900 | $241.69 | $700,894 | 90,875 (Indirect Direct) | View |
| 2025-02-28 Sale | 2025-03-03 4:31 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 796 | $241.7 | $192,390 | 35,863 (Indirect Direct) | View |
| 2025-02-28 Sale | 2025-03-03 4:31 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 513 | $241.68 | $123,983 | 16,011 (Direct) | View |
| 2025-02-28 Sale | 2025-03-03 4:31 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 935 | $241.69 | $225,977 | 15,551 (Indirect Direct) | View |
| 2025-02-28 Sale | 2025-03-03 4:30 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 496 | $241.69 | $119,878 | 12,922 (Indirect Direct) | View |
| 2025-02-14 Sale | 2025-02-18 4:49 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 1,213 | $255.17 | $309,527 | 81,933 (Indirect Direct) | View |
| 2025-02-14 Sale | 2025-02-18 4:47 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 967 | $255.17 | $246,750 | 32,843 (Indirect Direct) | View |
| 2025-02-14 Sale | 2025-02-18 4:47 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 2,103 | $252.71 | $531,448 | 13,418 (Indirect Direct) | View |
| 2025-02-14 Sale | 2025-02-18 4:47 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 3,109 | $253.43 | $787,904 | 12,670 (Indirect Direct) | View |
| 2025-01-27 Sale | 2025-01-29 4:03 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 52,592 | $285 | $14,988,720 | 12,670 (Indirect Direct) | View |
| 2025-01-23 Sale | 2025-01-24 4:10 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director | 11,250 | $275 | $3,093,750 | 266,899 (Indirect Direct) | View |
| 2024-12-12 Sale | 2024-12-13 4:13 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 1,752 | $251 | $439,760 | 16,386 (Indirect Direct) | View |
| 2024-11-26 Sale | 2024-11-27 5:22 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 5,219 | $250.98 | $1,309,853 | 79,287 (Indirect Direct) | View |
| 2024-11-26 Sale | 2024-11-27 5:22 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 1,682 | $250.98 | $422,144 | 18,138 (Indirect Direct) | View |
| 2024-11-26 Sale | 2024-11-27 5:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,682 | $250.98 | $422,144 | 30,701 (Indirect Direct) | View |
| 2024-11-26 Sale | 2024-11-27 5:21 pm | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,469 | $250.98 | $368,686 | 13,191 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-07-01 Option Award | 2025-07-02 4:26 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 7,763 | $0 | 21,801 (Direct) | View |
| 2025-05-30 Exercise | 2025-06-03 4:10 pm | N/A 2030-02-25 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 50,937 | $0 | 72,024 (Direct) | View |
| 2025-05-30 Exercise | 2025-06-03 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 24,161 | $119.13 | 72,024 (Direct) | View |
| 2025-05-30 Exercise | 2025-06-03 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 26,776 | $118.05 | 72,024 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-19 4:17 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director | 11,250 | $131.21 | 20,804 (Direct) | View |
| 2025-05-15 Exercise | 2025-05-19 4:17 pm | 2016-06-01 2025-06-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director | 11,250 | $0 | 20,804 (Direct) | View |
| 2025-05-16 Gift | 2025-05-19 4:16 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 8,376 | $0 | 49,355 (Direct) | View |
| 2025-05-08 Option Award | 2025-05-12 4:07 pm | 2026-05-08 2035-05-08 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Ausiello Dennis A Director | 2,333 | $0 | 5,969 (Direct) | View |
| 2025-05-08 Option Award | 2025-05-12 4:07 pm | 2026-05-08 2035-05-08 | ALNYLAM PHARMACEUTICALS INC. | ALNY | BONNEY MICHAEL W Director | 2,333 | $0 | 22,362 (Direct) | View |
| 2025-05-08 Option Award | 2025-05-12 4:06 pm | 2026-05-08 2035-05-08 | ALNYLAM PHARMACEUTICALS INC. | ALNY | BRANDICOURT OLIVIER Director | 2,333 | $0 | 2,333 (Direct) | View |
| 2025-05-08 Option Award | 2025-05-12 4:06 pm | 2026-05-08 2035-05-08 | ALNYLAM PHARMACEUTICALS INC. | ALNY | HAMBURG MARGARET A Director | 2,333 | $0 | 2,469 (Direct) | View |
| 2025-05-08 Option Award | 2025-05-12 4:05 pm | 2026-05-08 2035-05-08 | ALNYLAM PHARMACEUTICALS INC. | ALNY | KELLOGG PETER N Director | 2,333 | $0 | 2,333 (Direct) | View |
| 2025-05-08 Option Award | 2025-05-12 4:05 pm | 2026-05-08 2035-05-08 | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 2,333 | $0 | 30,369 (Direct) | View |
| 2025-05-08 Option Award | 2025-05-12 4:05 pm | 2026-05-08 2035-05-08 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Reitan Colleen F Director | 2,333 | $0 | 2,333 (Direct) | View |
| 2025-05-08 Option Award | 2025-05-12 4:04 pm | 2026-05-08 2035-05-08 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 2,333 | $0 | 13,519 (Direct) | View |
| 2025-05-08 Option Award | 2025-05-12 4:04 pm | 2026-05-08 2035-05-08 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Sigal Charles Elliott Director | 2,333 | $0 | 4,333 (Direct) | View |
| 2025-05-08 Option Award | 2025-05-12 4:03 pm | 2026-05-08 2035-05-08 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Bertozzi Carolyn R Director | 2,333 | $0 | 2,333 (Direct) | View |
| 2025-05-02 Gift | 2025-05-06 5:05 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 41,311 | $0 | 57,731 (Direct) | View |
| 2025-03-24 Exercise | 2025-03-25 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 5,445 | $42.22 | 20,902 (Direct) | View |
| 2025-03-24 Exercise | 2025-03-25 4:10 pm | N/A 2026-12-20 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 5,445 | $0 | 20,902 (Direct) | View |
| 2025-03-24 Exercise | 2025-03-25 4:09 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 7,440 | $88.95 | 28,036 (Direct) | View |
| 2025-03-24 Exercise | 2025-03-25 4:09 pm | N/A 2025-12-18 | ALNYLAM PHARMACEUTICALS INC. | ALNY | PYOTT DAVID E I Director | 7,440 | $0 | 28,036 (Direct) | View |
| 2025-03-13 Exercise | 2025-03-14 4:16 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 2,750 | $131.21 | 11,186 (Direct) | View |
| 2025-03-13 Exercise | 2025-03-14 4:16 pm | 2016-06-01 2025-06-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SCHULMAN AMY W Director | 2,750 | $0 | 11,186 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:23 pm | N/A 2035-03-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Hesslein Robert W. EVP, CLO and Secretary | 2,286 | $0 | 9,531 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:22 pm | N/A 2035-03-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 11,690 | $0 | 21,857 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:22 pm | N/A 2035-03-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 21,956 | $0 | 35,830 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:21 pm | N/A 2035-03-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 21,956 | $0 | 33,042 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:21 pm | N/A 2035-03-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 24,917 | $0 | 57,608 (Direct) | View |
| 2025-03-03 Option Award | 2025-03-05 4:20 pm | N/A 2035-03-03 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 54,258 | $0 | 135,335 (Direct) | View |
| 2025-02-27 Exercise | 2025-03-03 4:32 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 5,921 | $0 | 90,875 (Direct) | View |
| 2025-02-27 Exercise | 2025-03-03 4:31 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 1,908 | $0 | 35,863 (Direct) | View |
| 2025-02-27 Exercise | 2025-03-03 4:31 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 1,667 | $0 | 16,011 (Direct) | View |
| 2025-02-27 Exercise | 2025-03-03 4:31 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 1,908 | $0 | 15,551 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-18 4:49 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 3,859 | $0 | 81,933 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-18 4:47 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,109 | $0 | 32,843 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-18 4:47 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Fitzgerald Kevin Joseph CSO & EVP, Head of Research | 2,103 | $0 | 13,418 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-18 4:47 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 3,109 | $0 | 12,670 (Direct) | View |
| 2025-01-27 Exercise | 2025-01-29 4:03 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 48,876 | $88.95 | 12,670 (Direct) | View |
| 2025-01-27 Exercise | 2025-01-29 4:03 pm | 2019-08-06 2025-12-18 | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 48,876 | $0 | 12,670 (Direct) | View |
| 2025-01-23 Exercise | 2025-01-24 4:10 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director | 11,250 | $131.21 | 266,899 (Direct) | View |
| 2025-01-23 Exercise | 2025-01-24 4:10 pm | 2016-06-01 2025-06-01 | ALNYLAM PHARMACEUTICALS INC. | ALNY | SHARP PHILLIP A Director | 11,250 | $0 | 266,899 (Direct) | View |
| 2024-11-25 Option Award | 2024-11-27 5:22 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Greenstreet Yvonne Chief Executive Officer | 10,658 | $0 | 79,287 (Direct) | View |
| 2024-11-25 Option Award | 2024-11-27 5:22 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Garg Pushkal CMO & EVP Dev & Med Affairs | 3,434 | $0 | 18,138 (Direct) | View |
| 2024-11-25 Option Award | 2024-11-27 5:21 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Poulton Jeffrey V. EVP, Chief Financial Officer | 3,434 | $0 | 30,701 (Direct) | View |
| 2024-11-25 Option Award | 2024-11-27 5:21 pm | N/A N/A | ALNYLAM PHARMACEUTICALS INC. | ALNY | Tanguler Tolga EVP, Chief Commercial Officer | 3,000 | $0 | 13,191 (Direct) | View |